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Abstract
Background: The causes of death on long-term mortality after acute kidney injury (AKI) have not been well studied. The
purpose of the study was to evaluate the role of comorbidities and the causes of death on the long-term mortality after AKI.
Methodology/Principal Findings: We retrospectively studied 507 patients who experienced AKI in 2005–2006 and were
discharged free from dialysis. In June 2008 (median: 21 months after AKI), we found that 193 (38%) patients had died. This
mortality is much higher than the mortality of the population of Sa˜o Paulo City, even after adjustment for age. A multiple
survival analysis was performed using Cox proportional hazards regression model and showed that death was associated
with Khan’s index indicating high risk [adjusted hazard ratio 2.54 (1.38–4.66)], chronic liver disease [1.93 (1.15–3.22)],
admission to non-surgical ward [1.85 (1.30–2.61)] and a second AKI episode during the same hospitalization [1.74 (1.12–
2.71)]. The AKI severity evaluated either by the worst stage reached during AKI (P = 0.20) or by the need for dialysis (P = 0.12)
was not associated with death. The causes of death were identified by a death certificate in 85% of the non-survivors.
Among those who died from circulatory system diseases (the main cause of death), 59% had already suffered from
hypertension, 34% from diabetes, 47% from heart failure, 38% from coronary disease, and 66% had a glomerular filtration
rate ,60 previous to the AKI episode. Among those who died from neoplasms, 79% already had the disease previously.
Conclusions: Among AKI survivors who were discharged free from dialysis the increased long-term mortality was associated
with their pre-existing chronic conditions and not with the severity of the AKI episode. These findings suggest that these
survivors should have a medical follow-up after hospital discharge and that all efforts should be made to control their
comorbidities.
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Introduction
Recent studies have consistently shown that survivors of an
acute kidney injury (AKI) episode have increased long-term
mortality [1–3]. However, the risk factors associated with this
increase in long-term mortality are controversial.
Some studies have shown that the most important risk factors
for long-term mortality are the patient’s characteristics [1,3–8].
Lian˜o et al followed 177 survivors of AKI and reported a mortality
rate of 50% over a10 year period; the factors associated with the
worst prognoses were advanced age, male gender, the presence of
comorbidities and medical admission [1]. However, other studies
have associated AKI characteristics with long-term mortality [3–
7,9–16]. Lafrance and Miller, reviewing the data from US
veterans and following the patients for 2.3 years, showed that
patients who suffered an AKI episode that did not require dialysis
and who survived at least 90 days after the hospital discharge, had
a relative risk of 1.41 of long-term mortality. This risk increased
with increasing AKI severity [3]. In a systematic review, Coca et al
found a mortality rate of 8.9 deaths/100 person-years for patients
with AKI who survived hospitalization compared to 4.3 deaths/
100 person-years for those without AKI who survived hospital-
ization. The risk was greater for patients with moderate and severe
AKI. However, it is worth noting that the definition of AKI, as
well as the length of follow-up, varied among the included studies
[2].
To be able to propose interventions to decrease long-term
mortality, it is important to identify the causes of death. It is known
that the presence of chronic kidney disease (CKD) is a significant
risk factor for the development of cardiovascular diseases and that
the CKD population dies from these diseases [17]. However, it is
not known whether cardiovascular diseases are also associated
with long-term mortality after AKI. During the AKI episode, the
causes of death are related to the clinical situation in which AKI
develops, and the most important factor contributing to death is
the underlying cause of AKI [18,19]. Goldberg and Dennen noted
that although several articles highlight the presence of previous
comorbidities during the AKI episode, few investigate the
influence of these comorbid illnesses on long-term mortality [20].
Moreover, different results can be found in developing
countries because their populations may have different clinical
features, different AKI characteristics and different AKI
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treatments [21]. Cerda´ et al indicated that active research on the
epidemiology of AKI in developing countries should be
considered a priority [22].
Our objectives were to identify the ultimate causes of death
among the survivors of an AKI episode and the influence of
previous comorbidities on long-term mortality.
Materials and Methods
This is a retrospective study of patients hospitalized in two
institutes of Hospital das Clı´nicas in Sa˜o Paulo City (a general and
a cardiologic hospital) with AKI diagnosis and followed by the
same Nephrology Department. The study included AKI patients
older than 17 years of age hospitalized from January 2005 to
January 2007, who were discharged from hospital free from
dialysis.
Patients with CKD stage 5 [glomerular filtration rate (GFR)
,15 mL/min/1.73 m2 or reference serum creatinine (SCr)
.3.5 mg/dL], kidney transplantation and without reference SCr
were excluded. Patients discharged from the hospital receiving
dialysis treatment were excluded. In order to study only patients
with AKI caused by presumed acute tubular necrosis (ATN), those
patients with AKI caused by glomerulopathies, multiple myeloma,
urinary obstruction and obstetric conditions and those with less
than two days of follow-up were also excluded.
Definitions
AKI was defined at the first nephrology consultation as an
absolute rise of 0.30 mg/dL or 50% in SCr achieved at that
time relative to the reference SCr [3,23]. Reference SCr was
defined as the lowest SCr value found in the last 6 months
before AKI or, for those without this measurement, the lowest
value achieved during hospitalization in the absence of dialysis
[24,25]. GFR was estimated using the ‘‘Modification of Diet in
Renal Disease’’ (MDRD) abbreviated equation [26]. A reference
GFR ,60 mL/min/1.73 m2 was considered as presumed CKD.
Severity of AKI was classified into stage I, II or III according to
the ratio between the highest SCr found during the AKI
episode and the reference SCr: stage I #2, stage II 2 to 3, and
stage III .3. All patients who needed dialysis were classified as
stage III [3,23]. AKI etiology was classified as ischemic (due to
low cardiac output, hypovolemia, or hepato-renal syndrome),
nephrotoxic (associated with drugs or heme pigments) or septic
(sepsis or septic shock) [27]. Renal recovery was defined
according to the ratio between the GFR at hospital discharge
and the reference GFR: complete $90%; partial ,90% and
$50%; no recovery ,50% [3]. Type of admission was classified
as surgical or non-surgical according to the type of ward where
the patient was admitted. The presence of the following pre-
existing comorbidities was determined: hypertension, diabetes,
heart failure, cancer, and chronic liver, coronary, pulmonary
and vascular diseases. The patients were also stratified into
three categories of risk using the Khan index; low risk: age ,70
and no comorbidity; medium risk: age .70 and ,80, or age
,80 with one comorbidity; high risk: age .80, or any age with
two or more comorbidities, or any age with malignancy [28,29].
Other variables analyzed include age, gender, length of stay
(LOS), length of Nephrology Department follow-up, intensive
care unit (ICU) admission, need for dialysis, mechanical
ventilation and vasoactive drugs and the presence of a second
episode of AKI during the same hospitalization (defined as a
Figure 1. Flow-chart showing the selection process. CKD: chronic kidney disease Scr: serum creatinine.
doi:10.1371/journal.pone.0047746.g001
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Figure 2. Kaplan-Meier survival curves of (a) the patients discharged alive after an AKI episode (solid line) and of the population of
Sa˜o Paulo city (dashed line); (b) Comparison of the effect of age on survival in patients discharged alive after AKI and in the
population of Sa˜o Paulo city. Solid lines represent the survival curves of AKI patients, and dashed lines represent the survival of the Sa˜o Paulo
population. Regular lines represent patients and population aged ,65 years, and bold lines represent patients and population $65 years.
doi:10.1371/journal.pone.0047746.g002
Comorbidities and Long-Term Mortality after AKI
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new call for the nephrologist after a previous nephrological
discharge).
Search for Long-term Outcome
The index date to determine the outcome was May31, 2008.
The patients alive at this date were classified as ‘‘survivors’’.
The situation of each patient at the index date was obtained in
the hospital database system by searching for either a report of
death after hospital discharge (non-survivor) or for a medical
consultation after the index date (survivor). We also consulted
PRO-AIM, a register of death certificates in Sa˜o Paulo City
(PRO-AIM is the Portuguese abbreviation for Program for
Improvement of Death Cause Information). In the case of
patients for whom we were unable to obtain information, we
attempted phone contact. Causes of death were identified on
the death certificate obtained in PRO-AIM and were classified
according to the codes of ‘‘International classification of
diseases, 10th revision’’ (ICD-10). They were compared with
the causes of death of the population of Sa˜o Paulo City, which
was also obtained in PRO-AIM [30].
Statistical Analysis
Continuous variables are presented as the median and
interquartile range (IQR) and are compared using the Mann-
Whitney test. Categorical variables are presented as absolute
values and percentages and are compared by Fisher or Chi-
square tests as appropriate. The graphical survival curve of our
patients was compared with that of the Sa˜o Paulo population
and matched for age. The survival curve of the Sa˜o Paulo
population was estimated until 2008 and drawn using data
available from the ‘‘Brazilian Institute of Geography and
Statistics’’ (IBGE) and SEADE (SEADE is the Portuguese
abbreviation for the System for Data Analysis of the State of
Sa˜o Paulo) [31,32]. Survival curves were estimated by the
Kaplan-Meier method, and differences between curves were
assessed with the log-rank test. A multiple survival analysis was
performed using Cox proportional hazards regression analyses.
The variables with P,0.15 in the univariate analysis were
included in the first model: gender (reference: male); age
(reference: ,65 years); presence of chronic liver disease, heart
failure, cancer and presumed CKD (reference: absence); Khan
index (reference: low-risk); type of admission (reference: surgi-
cal); ICU admission (reference: no ICU); nephrotoxic or septic
etiology (reference: absence); AKI severity (reference: stage I);
need for mechanical ventilation (reference: no need) and second
AKI (reference: absence). The proportional hazards test and
plotted cumulative survival estimate after ln (-ln) transformation
suggested that the hazards of these variables were proportional
for the period analyzed. Statistical analysis was performed using
Graph Pad Prism version 5.0 and SPSS version 15.0 for
Windows.
The Research Ethics Committees of the Hospital das Clı´nicas
and of the Municipal Health Department of Sa˜o Paulo City
approved the study (numbers: 0621/09 and 264/08, respectively)
and waived informed consent because there was no intervention,
the study was retrospective and the study used only a data bank,
where confidentiality was guaranteed.
Table 1. Characteristics of the included patients.
All Survivors Non-survivors P*
N=507 N=314 N=193
Male gender n (%) 311 (61) 197 (63) 114 (59) 0.45
Age $65 years n (%) 266 (52) 135 (43) 106 (55) 0.01
Comorbidities n (%)
Hypertension 287 (57) 178 (57) 109 (56) 1.00
Diabetes 166 (33) 100 (32) 66 (34) 0.62
Chronic liver
disease
44 (9) 21 (7) 23 (12) 0.05
Heart failure 108 (21) 55 (17) 53 (27) 0.01
Cancer 94 (18) 44 (14) 49 (25) 0.002
Presumed CKD n (%) 260 (51) 151 (48) 109 (56) 0.07
Khan index n (%) ,0.0001
Low risk 100 (20) 83 (26) 17 (9)
Medium risk 195 (38) 125 (40) 70 (36)
High risk 212 (42) 106 (34) 106 (55)
Type of admission
n (%)1
0.0025
Surgical 167 (33) 119 (38) 48 (25)
Non-surgical 339 (67) 194 (62) 145 (75)
ICU admission
n (%)
%
285 (58) 187 (61) 98 (53) 0.11
*Comparison between survivors and non-survivors, Fisher’s exact test or chi-
square n,number of patients; CKD: chronic kidney disease; ICU, intensive care
unit;
1missing data in 1 patient
%missing data in 15 patients
doi:10.1371/journal.pone.0047746.t001
Table 2. Characteristics of the acute kidney injury episode.
All Survivors
Non-
survivors P*
N=507 N=314 N=193
AKI etiology n (%)&
Ischemic 367 (73) 225 (72) 142 (75) 0.67
Septic 160 (32) 109 (35) 51 (27) 0.06
Nephrotoxic 149 (30) 101 (32) 48 (25) 0.08
AKI severity n (%) 0.20
stage I 135 (27) 81 (26) 54 (29)
stage II 122 (24) 69 (22) 53 (27)
stage III 250 (49) 164 (52) 86 (44)
Dialysis n (%) 131 (26) 89 (28) 42 (22) 0.12
Mechanical
ventilation n (%)¥
161 (33) 115 (37) 46 (26) 0.001
Vasoactive
drug n (%)1
205 (40) 136 (43) 69 (36) 0.09
Recovery of renal
function n. (%)
0.87
No 70 (14) 42 (13) 28 (15)
Partial 185 (36) 117 (37) 68 (35)
Complete 252 (50) 155 (50) 97 (50)
Second AKI n. (%) 40 (8) 16 (5) 24 (12) 0.004
*Comparison between survivors and non-survivors, Fisher’s exact test or chi-
square.
AKI, acute kidney injury; n, number of patients;
& missing data in 7 patients.
¥missing data in 21 patients.
1missing data in 1 patient.
doi:10.1371/journal.pone.0047746.t002
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Results
Of the 740 AKI patients who had been attended by the
Nephrology Department of Hospital das Clı´nicas, Sa˜o Paulo City,
during the study period, and discharged alive, 193 were excluded
for the reasons shown in Figure 1, and 547 were included.
However, 40 patients were lost (7%) because we could not
determine their situation at the index date in the end of the study.
The remaining 507 patients were followed for 21 months (10–30
months). At the index date, 193 patients (38% of those studied)
had died, and death occurred 5 months (2–14 months) after
hospital discharge.
The comparison of the survival curve of AKI patients with that
of the population of Sa˜o Paulo City (Figure 2a) showed a much
poorer survival for the AKI patients. The difference persisted even
after age stratification (Figure 2b).
The patients’ characteristics are shown in Table 1.The median
age of the patients was 63 years (51–73 years). Those who died
during the study period (non-survivors) were older than survivors
[68 years (53–76 years) and 61 years (48–78 years), respectively,
P,0.0001] and had a higher Khan index. Among the 507 studied
patients, only 26 (5%) had no comorbidity.
The characteristics of AKI are presented in Table 2. LOS was
similar between the groups: 30 days (17–56 days) for the survivors
and 28 days (13–62 days) for the non-survivors (P = 0.45). The
length of the nephrological follow-up was also similar between the
groups: 8 days (4–14) for the survivors and 7 days (4–13) for the
non-survivors (P = 0.12).
For 49 patients (9.6%), we used the lowest SCr value achieved
during hospitalization as the reference SCr. Although the
reference GFR tended to be lower in the non-survivors than in
the survivors [57 (35–75) and 61 mL/min/1.73 m2 (39–88),
respectively, P,0.08], the presence of presumed CKD was similar
in both groups. The maximum SCr value achieved during the
AKI was similar in both groups: 3.5 mg/dL (2.7–4.9 mg/dL) in
non-survivors and 3.8 mg/dL (2.8–5.2 mg/dL) in survivors
(P = 0.27). The severity of the AKI was also similar between the
groups. At hospital discharge, the SCr value was 1.4 mg/dL (1.0–
2.0 mg/dL) in the survivors and 1.5 mg/dL (1.0–2.1 mg/dL) in
the non-survivors (P = 0.18). At the time of hospital discharge, 252
Figure 3. Cox survival curves according to Khan index. Solid line: low risk; dotted line: medium risk; dashed line: high risk. Adjusted for:
gender; age; presence of cancer, heart failure, and presumed chronic kidney disease; nephrotoxic and septic etiologies.
doi:10.1371/journal.pone.0047746.g003
Comorbidities and Long-Term Mortality after AKI
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patients (50%) presented complete renal recovery, and this rate
was similar between the survivors and the non-survivors, as shown
in Table 2.
ICU admission and the need for mechanical ventilation were
not significant in the first Cox regression model tested. Due to the
number of missing values in these variables, a second model was
evaluated without these two variables. The significant variables in
the final Cox model are presented in Table 3. The independent
variables associated with long-term mortality were as follows:
classification of high risk according to the Khan index, presence of
chronic liver disease, non-surgical admission and presence of a
second episode of AKI (Figures 3–6, Table 3).
Causes of Death
We obtained the death certificate of 164 non-survivors (85%).
The main causes of death were diseases of the circulatory system
(28%) and neoplasms (20%). Among the 47 patients who died
from diseases of the circulatory system, 28 (59%) had hyperten-
sion, 16 (34%) had diabetes, 22 (47%) had heart failure, 18 (38%)
had coronary diseases, and 31 (66%) had presumed CKD before
the AKI episode. Among the 33 patients who died from
neoplasms, 26 (79%) already had the disease at the time of
hospitalization for the AKI episode. Only 19 non-survivors (11%)
had none of the comorbidities cited above, and their main causes
of death were diseases of the digestive system (7 patients, 37%) and
diseases of the circulatory system (4 patients, 21%).
The causes of death of the AKI patients are presented in Table 4
and are compared with the causes of death for the population of
Sa˜o Paulo City of a similar age. For this analysis, the age of the
AKI patients was divided into quartiles. The frequency of the
main causes of death of the AKI patients was similar to that of the
general population except in the first age quartile, or 18–50 years.
The causes of death among the youngest AKI patients were
neoplasms and diseases of the circulatory system (18% each), while
the population of Sa˜o Paulo City in the same age range died
mainly from external causes (32%).
The main causes of death of the patients who died up to 6
months after hospital discharge were diseases of the circulatory
system and neoplasms (24% each). Otherwise, after this period
only 15% of deaths were due to neoplasms.
It is important to note that the patients who suffered a second
AKI episode died from the same diseases as those who had not,
Figure 4. Cox survival curves according to chronic liver disease. Solid line: absence; dotted line: presence. Adjusted for: gender; age;
presence of cancer, heart failure, and presumed chronic kidney disease; nephrotoxic and septic etiologies.
doi:10.1371/journal.pone.0047746.g004
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including diseases of the circulatory system, neoplasms and
diseases of the respiratory system.
Discussion
The present study showed that patients who suffered an AKI
episode caused by presumed ATN, who were followed by
nephrologists during hospitalization and who were discharged
free from dialysis remains with a high mortality even after hospital
discharge. This mortality was much higher than those of the
population of Sa˜o Paulo City, and also higher than those reported
in other studies [3,33]. One explanation could be that we included
all deaths occurred after hospital discharge (median time to death
was 5 months) and some studies excluded the deaths up to 90 days
[3,33,34].
Since half of non-survivors died in the first 6 months after
discharge, and neoplasm was a much higher cause of death than in
those who died after this period, it is reasonable to suppose that the
high early mortality observed occurred in the most severely
diseased patients.
The present study highlights the importance of previous
comorbidities in long-term mortality after AKI. It showed that
patients classified as high risk by the Khan index, those with
chronic liver failure, those who were admitted to non-surgical
services and those who had a second episode of AKI had a very
high risk of death after hospital discharge.
The role of previous comorbidities on long-term mortality was
more clearly shown by the finding that the non-survivors died
from diseases already present before the AKI episode and that
their causes of death were similar to the population of Sa˜o Paulo
City in the same age range.
The Khan index was first described as an indicator of the risk of
mortality for patients with end-stage renal disease (ESRD) and was
later transposed to AKI patients [35]. Ali et al showed that the
index was associated with 6-month mortality after AKI [28]. In
the present study, the patients classified as high risk by the Khan
index had a poorer survival rate than those classified as low risk.
There was a trend (P = 0.08) suggesting that the patients classified
as medium risk also had a poorer prognosis than the low risk
patients.
In addition to its presence on the Khan index, the presence of
chronic liver disease was an independent factor associated with
long-term mortality. It has been reported that the occurrence of
Figure 5. Cox survival curves according to type of ward admission. Solid line: surgical; dotted line: non-surgical. Adjusted for: gender; age;
presence of cancer, heart failure, and presumed chronic kidney disease; nephrotoxic and septic etiologies.
doi:10.1371/journal.pone.0047746.g005
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AKI is frequent in patients with chronic liver failure and that it
increases morbidity and mortality [36]. Even for patients who had
received a liver transplant, a reduced GFR before the transplant
was an independent predictor of mortality 30 days and 2 years
after the transplantation [37]. Deshpande et al propose that the
combination of AKI and liver failure produces a ‘‘toxic milieu’’
that directly causes endothelial dysfunction affecting multiple
organ systems, which contributes to the increased short- and long-
term mortality of these patients [36]. Our findings emphasize the
catastrophic role of the interaction between chronic liver disease
and AKI.
Admission to non-surgical wards was an independent factor
associated with long-term mortality that could not be explained by
the presence of any of the variables analyzed. Other studies have
also found a poorer survival among non-surgical admissions, and
this finding has not yet been explained [1,10].
The impact that a second episode of AKI has on in-hospital
mortality has not been studied. In the present study, only 8% of
the patients had a second episode of AKI during the same
hospitalization; however, those who did have a second episode
were at very high risk for long-term mortality. More studies are
needed to evaluate the importance of a new AKI episode both on
in-hospital mortality and on long-term mortality.
Data from animal studies have already shown that AKI can
induce damage to other organs, such as the lungs [38] and heart
[39]. Thus, each AKI episode may aggravate pre-existing
dysfunctions of various organs, accelerating their decline and
leading to death.
AKI may also aggravate previous kidney disease, accelerate the
progression to ESRD and worsen survival rates. Experimental
studies have shown that AKI induces permanent kidney damage
[40–42]. However, human studies are controversial, mainly
because many studies on long-term mortality exclude patients
with CKD [1,5–7,13]. Some studies have shown that in-hospital
mortality is lower in patients with AKI superimposed on CKD
(AoCKD) when compared with patients with ‘‘pure’’ AKI [43,44].
However, Ali et al showed that the 6-month mortality of patients
with AoCKD was higher than those with AKI (62.5% and 49.8%,
respectively, P = 0.038) [28]. Long-term mortality was not
associated with pre-existing CKD in the present study. However,
we must note that our percentage of patients with presumed CKD
(51%) was much higher than those reported by Ali et al (15%). This
Figure 6. Cox survival curves according to the presence of a second AKI episode during the same hospitalization. Solid line: absence;
dotted line: presence. Adjusted for: gender; age; presence of cancer, heart failure, and presumed chronic kidney disease; nephrotoxic and septic
etiologies.
doi:10.1371/journal.pone.0047746.g006
Comorbidities and Long-Term Mortality after AKI
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difference may be because in the present study, all patients were
seen by nephrologists, while in the Ali et al study, the nephrologists
attended only 29% of the patients [28].
Another controversial point is whether AKI severity is a good
predictor of long-term mortality, as it has been shown to be for in-
hospital mortality [45]. Usually AKI severity can be evaluated by
AKIN or RIFLE criteria. As there is no widely accepted AKI
definition for retrospective research using databases, we defined
AKI considering the adapted AKIN definition [46]. This
definition uses the ratio between the higher SCr measured during
hospitalization and the previous SCr to define and classify the AKI
episode and has been used by other authors [3,11,12,14]. In
contrast to these studies, which have shown that this classification
can also predict long-term mortality [3,11,12,14], in the present
study, AKI severity was not a risk factor for long-term mortality.
One factor may explain this difference; as mentioned earlier, we
only included patients followed by nephrologists. Ponce et al
showed that AKI patients evaluated by nephrologists were more
seriously ill than those not evaluated [47]. This finding may
explain why 49% of our patients were classified as AKI severity
III, while other authors, who also evaluated patients not attended
by nephrologists, reported that 13% of patients were classified as
AKI severity III [3]. Moreover, patient with pre-renal AKI were
not evaluated in the present study, as those with less than two days
of follow-up were excluded.
Some studies found that the absence of renal recovery was a risk
factor for long-term mortality [3,7,13], but in the present study,
renal recovery was not associated with long-term mortality.
Similar to our findings, Loef et al did not find a difference in
mortality 96 months after the AKI episode between those who
recovered and those who did not show renal function recovery
[48]. Conversely, Mehta et al showed that, 13 years after cardiac
surgery, the survival curve of the patients who did not show renal
function recovery was poorer than that of those who had
recovered (P = 0.046) [13]. However, in the present study patients
who were discharged on dialysis and also those with AKI not due
to presumed ATN were excluded. These exclusions might explain
this difference. It must be noted that the definition of renal
recovery varies among studies, and it may be more appropriate to
use a SCr measured after hospital discharge to define renal
recovery [49].
The present study has some limitations. The lack of a control
group, similar to the studied population but without AKI, does
not allow us to establish a causal relationship between AKI and
long-term mortality. Although we attempted to control for
selection bias with statistical methods using multiple variables,
our retrospective observational analysis is subject to bias from
unmeasured factors. However, it is very difficult to find a
matched control group. Wald et al, who studied 4066 AKI
survivors, had to exclude 297 more seriously ill patients because
Table 3. Final Cox model.
Reference
value HR CI P
Khan Index
Low risk 1
Medium risk 1.666 0.930–2.986 0.086
High risk 2.540 1.382–4.669 0.003
Presence of comorbidity
Chronic liver disease Absence 1
Presence 1.932 1.159–3.220 0.012
Type of admission
Surgical 1
Non-surgical 1.851 1.309–2.619 ,0.001
Second AKI
Absence 1
Presence 1.748 1.124–2.719 0.013
HR, Hazard ratio; CI, confidence interval; AKI, acute kidney injury.
Adjusted for: age, gender, presence of cancer, heart failure and presumed
chronic kidney disease, septic and nephrotoxic etiologies.
doi:10.1371/journal.pone.0047746.t003
Table 4. Causes of death of the patients with acute kidney injury and of the Sa˜o Paulo population.
Age Cause of death (ICD-10) (%)
AKI Population of Sa˜o Paulo City*
18–50 years 1. Neoplasms and Diseases of the circulatory system
(18% each one)
1. External causes of morbidity and mortality (32%)
2. Certain infectious and parasitic diseases (15%) 2. Diseases of the circulatory system (18%)
3. Neoplasms (15%)
51–62 years 1. Diseases of the circulatory system (20%) 1. Diseases of the circulatory system (28%)
2. Diseases of the respiratory system (18%) 2. Neoplasms (28%)
3. Neoplasms (16%) 3. Diseases of the respiratory system (8%)
63–73 years 1. Neoplasms (22%) 1. Diseases of the circulatory system (40%)
2. Diseases of the circulatory system (20%) 2. Neoplasms (26%)
3. Diseases of the respiratory system and Diseases of the
digestive system (10% each one)
3. Diseases of the respiratory system (12%)
74–95 years 1. Diseases of the circulatory system (33%) 1. Diseases of the circulatory system (39%)
2. Diseases of the respiratory system (17%) 2. Diseases of the respiratory system (18%)
3. Neoplasms (14%) 3. Neoplasms (18%)
AKI, acute kidney injury; ICD-10, International classification of diseases, 10th revision.
*Data from PRO-AIM.
doi:10.1371/journal.pone.0047746.t004
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they could not match these patients to an adequate control
[34]. In the present study, we compared the long-term survival
of AKI patients with the population of Sa˜o Paulo City at the
same age and found poorer survival among AKI patients.
Although the general population is not an ideal control group, a
similar approach was taken by Lian˜o et al, who compared the
mortality of AKI patients with the mortality of the population
of Madrid and found poorer survival among AKI patients [1].
The use of death certificates to address the cause of death is
subject to bias, as it depends on the person who completed the
certificate. In 2005, the World Health Organization (WHO)
examined the quality of the death certificates in 115 countries
and classified the Brazilian death certificates to be of medium
quality, based on the percentage of incomplete data and ill-
defined codes [50]. However, Franc¸a et al analyzed the data in
various regions of Brazil and found that the quality of the data
was high in the southeast (where Sa˜o Paulo City is located)
[51]. Moreover, we observed that only 5 death certificates (3%)
had an improperly defined code as the cause of death.
The present study only included patients followed by nephrol-
ogists, and thus, some patients with AKI may have not been
evaluated (presumably those with less severe disease). Other
important studies, primarily those based on the Program to
Improve Care in Acute Renal Disease (PICARD), also included
only patients attended by nephrologists [1,44]. The results of the
present study cannot be generalized. However, they point to the
main importance of pre-existing comorbidities in patients with
AKI due to presumed ATN who were discharged free from
dialysis.
Our study also has several strengths. It was conducted in a
developing country, where there is a lack of true epidemiologic
studies on AKI [21,22]. We used a globally accepted AKI
definition that was based not on a calculated reference Scr but
on a reported reference Scr [3,11,12,14]. We lost only 40
patients (7%) after hospital discharge (Figure 1). We were also
able to clearly characterize the AKI episode, which allowed us
to adjust the analysis of outcomes for many important factors.
To the best of our knowledge it was the first time that the
causes of long-term mortality were carefully studied.
In conclusion, long-term mortality after an AKI episode due to
presumed ATN is high and is more closely related to previous
comorbidities than to the characteristics of the AKI. In our view,
all survivors of AKI should have a medical follow-up after hospital
discharge and all efforts should be made to control their
comorbidities.
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